nmsg

Four presentations from Nerviano Medical Sciences at the 2015 AACR meeting

Nerviano,  March 18, 2015 - Nerviano Medical Sciences will present four posters, one selected for an oral presentation, at the American Association for Cancer Research (AACR) Annual Meeting 2015, April 18 - 22, 2015, Pennsylvania Convention Center, Philadelphia, Pennsylvania.

Presentation title: Establishment and characterization of the new sacral chordoma cell line Chor-IN-1
Authors: Paola Magnaghi et al
Meeting: AACR Annual Meeting 2015, Abstract number 74
Presentation Time: Sunday, Apr 19, 2015, 1:00 PM - 5:00 PM



Presentation Title: NMS-P088, a dual FLT3-KIT inhibitor active also on gatekeeper mutations and devoid of QTc prolongation
Authors: Ciomei, M et al
Meeting: AACR Annual Meeting 2015, Abstract number 798
Presentation Time: Sunday, Apr 19, 2015, 1:00 PM - 5:00 PM


Presentation title: Preclinical characterization of the novel TTK kinase inhibitor S81694 for the treatment of triple negative breast cancer
Authors: Riccardo Colombo et al
Meeting: AACR Annual Meeting 2015, Abstract number 1638
Presentation Time: Monday, Apr 20, 2015, 8:00 AM -12:00 PM


Presentation title: Preclinical characterization of NMS-P648, a novel and potent PARP-1/-3 inhibitor
Authors: Alessia Montagnoli et al
Meeting: AACR Annual Meeting 2015, Abstract number 2851
Presentation Time: Monday, Apr 20, 2015, 3:50 PM - 4:05 PM


The last poster has been selected for an oral presentation:
Session title: PARP and DNA Repair Inhibitors
Session type: Minisymposium
Session Start/End Time: Monday, Apr 20, 2015, 3:00 PM - 5:00 PM
Location: Room 108, Pennsylvania Convention Center


The full abstracts can be found on the conference website: http://www.aacr.org

 
To give you a better browsing experience, NMS Group and Group Companies use own and third part cookies.
Browsing this web site, you allow to use them, according to our  
Cookie Policy.